Multi-center Randomized Controlled Clinical Study of Shenling Baishu Granule to Prevent the Recurrence of Low-risk Colorectal Adenoma

NCT06930157 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

624

Enrollment

OTHER

Sponsor class

Conditions

Low-risk Colorectal Adenoma

Interventions

DRUG: Shenling Baizhu granules (TCM patent medicine)

Sponsor

Shanghai Jiao Tong University School of Medicine

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]